Highlights |
Governor Cuomo Announces Inaugural NYFIRST Grant Recipients
Governor Andrew M. Cuomo today announced the inaugural grant recipients from the New York Fund for Innovation in Research and Scientific Talent, a $15 million medical school capital funding program to encourage recruitment and retention of exceptional life sciences researchers focused on translational research. The first round of grants awarded $1 million each to Columbia University Vagelos College of Physicians and Surgeons, Icahn School of Medicine at Mount Sinai and the University of Rochester School of Medicine & Dentistry. Take a closer look.
|
Weill Cornell Medicine: The Starr Foundation Reaffirms Support for Stem Cell Research With $50 Million Gift
The Starr Foundation is continuing its longstanding commitment to stem cell research in New York City with a $50 million gift in support of the Tri-Institutional Stem Cell Initiative (Tri-SCI), a research collaboration between Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine. The new gift reaffirms the foundation’s support and enhances collaborative, pioneering stem cell research at the three adjacent biomedical research institutions. Take a closer look.
|
Cancer |
Renaissance School of Medicine at Stony Brook University: New Hope to Treat Dangerous Triple-Negative Breast Cancer?
Triple-negative breast cancer is the most aggressive subtype of the disease, and people who have this form of breast cancer often end up with tumor recurrence and metastatic disease despite taking standard forms of chemotherapy. Now a team of researchers led by Lori Chan, PhD, Assistant Professor in the Department of Pharmacological Sciences in the Renaissance School of Medicine at Stony Brook University, have identified a specific gene involved in the cancer stem cell (CSC) population process of triple-negative breast cancer. Take a closer look.
|
Icahn School of Medicine at Mount Sinai and IBM Researchers Uncover Key to Greater Efficacy in Cancer Treatment
Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy. In a Nature Communications paper published today, researchers reveal for the first time that the number of mitochondria in a cell is, in great part, associated with how the cancer responds to drug therapy. Take a closer look.
|
Jacobs School of Medicine & Biomedical Sciences at University at Buffalo: Metastatic Prostate Cancer may Have its own Biomarker
Prostate cancer can grow slowly and pose little threat to patients, or it can metastasize quickly, causing severe pain and death. But as of now, it’s nearly impossible to determine which type of cancer a patient has during the early stages. Now, University at Buffalo researchers and scientists from Moscow State University are collaborating to determine how a biomarker for metastatic prostate cancer might best be detected. Take a closer look.
|
Neurology |
Albert Einstein College of Medicine: Some Children Can “Recover” From Autism, but Problems Often Remain
Research in the past several years has shown that children can outgrow a diagnosis of autism spectrum disorder (ASD), once considered a lifelong condition. In a new study, researchers at Albert Einstein College of Medicine and Montefiore Health System have found that the vast majority of such children still have difficulties that require therapeutic and educational support. The study was published online in the Journal of Child Neurology. Take a closer look.
|
University of Rochester School of Medicine & Dentistry: New Study Reshapes Understanding of how the Brain Recovers From Injury
Each year, approximately 265,000 Americans have a stroke that causes visual impairment. New research, which appears in the journal Proceedings of the Royal Society B,
sheds light on how the damage in the brain caused by a stroke can lead to permanent vision impairment. The findings could provide researchers with a blueprint to better identify which areas of vision are recoverable, facilitating the development of more effective interventions to encourage vision. Take a closer look.
|
Other Studies |
Columbia University Vagelos College of Physicians and Surgeons: With new Study, era of Open-Heart Surgery for Aortic Stenosis may be Ending
A multicenter clinical trial has found that transcatheter aortic valve replacement (TAVR) performed better than open-heart surgery in low-risk patients with severe aortic stenosis. The study found that one year after the procedure, the rate of death, stroke, or rehospitalization was significantly lower with TAVR than with surgery. Take a closer look.
|
University of Rochester School of Medicine & Dentistry: New Study Links Electronic Cigarettes and Wheezing in Adults
Electronic cigarette use (“vaping”) is associated with wheezing in adults, according to a new studypublished in the journal Tobacco Control. People who vaped were nearly twice as likely to experience wheezing compared to people who didn’t regularly use tobacco products. Wheezing, which is caused by narrowed or abnormal airways, is often a precursor to other serious health conditions such as emphysema, gastro-esophageal reflux disease, heart failure, lung cancer and sleep apnea. Take a closer look.
|
|
NYU School of Medicine: Study Shows That Patients With & Without Cancer use Different Forms of Marijuana
People with and without cancer are more likely, over time, to use a more potent form of medical marijuana with increasingly higher amounts of tetrahydrocannabinol (THC), a new study shows. In a report published in the Journal of Palliative Medicine on March 26, researchers say that people with cancer were more likely to favor forms of medical marijuana with higher amounts of THC, which relieves cancer symptoms and side effects of cancer treatment, including chronic pain, weight loss, and nausea. Take a closer look.
|
SUNY Upstate Medical University: Study Finds Resurgence of Malaria Cases at Ecuador-Peru Border Linked to Venezuela Crisis
In 2018, Ecuador and other countries in South America received a massive influx of Venezuelan migrants, who left their country following a social and economic collapse. The public health sector in Venezuela is struggling to control infectious disease epidemics, including measles, diphtheria, and malaria, presenting a major public health threat to the region. As a result, migrant populations and people living near border crossings are particularly susceptible to these infectious diseases. Take a closer look.
|
Weill Cornell Medicine: Artificial Intelligence Approach Optimizes Embryo Selection for IVF
A new artificial intelligence approach by Weill Cornell Medicine investigators can identify with a great degree of accuracy whether a 5-day-old, in vitro fertilized human embryo has a high potential to progress to a successful pregnancy. The technique, which analyzes time-lapse images of the early-stage embryos, could improve the success rate of in vitro fertilization (IVF) and minimize the risk of multiple pregnancies. Take a closer look.
|
|
NYU School of Medicine: Research Points to Ways to Reduce Opioid Use Following Common Orthopedic Surgeries
Opioid prescription rates can be significantly curbed following several orthopedic surgical procedures, according to new studies presented by researchers from NYU Langone Health’s Department of Orthopedic Surgery at the 2019 annual conference of the American Academy of Orthopaedic Surgeons (AAOS) in Las Vegas. Take a closer look.
|
Columbia University Vagelos College of Physicians and Surgeons: Scientists Detect Hidden Signals from Beneficial Bacteria
3D imaging is revealing how friendly bacteria communicate with their hosts to take up residence in the gut. The research, recently published in Science, could help shed new light on how beneficial bacteria in the gut strengthen the host’s immune system. Take a closer look.
|
Awards & Grants |
Albert Einstein College of Medicine: New $22 Million Project Targets Deadly Viruses
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded an international consortium led by Albert Einstein College of Medicine a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments. Take a closer look.
|
Zucker School of Medicine at Hofstra Northwell: Long Island Researchers Awarded for Combatting Lupus, Improving Telehealth
Feinstein Institute for Medical Research scientists and Zucker School of Medicine at Hofstra/Northwell faculty, Betty Diamond, MD, and Renee Pekmezaris, PhD, have earned Innovator of the Year awards for their respective medical innovations in the fields of lupus research and telehealth options geared towards the Spanish-speaking patient population. Take a closer look.
|
SUNY Upstate Medical University Researchers Collaborate on $1.9M NIH Study Examining Hearing Loss
An Upstate Medical University professor is one of four principal investigators involved in a study of genes linked to hearing loss that was recently awarded a $1.9 million grant by the National Institutes of Health. Francesca Pignoni, PhD, professor of ophthalmology and interim chair of neuroscience and physiology at Upstate, has been studying genetic mutations affecting development for many years. Take a closer look.
|
Jacobs School of Medicine & Biomedical Sciences at University at Buffalo Scientists Studying Krabbe’s Disease Take a Novel Approach to This Fatal Disease That Strikes Newborns
Rep. Brian Higgins visited the New York State Center of Excellence in Bioinformatics and Life Sciences on Monday to announce more than $2 million in National Institutes of Health funding to the Hunter James Kelly Research Institute. The funding allows UB researchers at the institute to pursue a new approach to Krabbe’s disease, also called globoid cell leukodystrophy, a rare, neurological disease that afflicts newborns and is fatal. Take a closer look.
|
Faculty News |
Columbia University Vagelos College of Physicians and Surgeons: David Ho and Aaron Diamond AIDS Research Center at Columbia
The Aaron Diamond AIDS Research Center for the City of New York (ADARC), the world’s largest private research center dedicated exclusively to fighting HIV/AIDS, will become a center within the Vagelos College of Physicians and Surgeons (VP&S), the two organizations announced. Take a closer look.
|
Icahn School of Medicine at Mount Sinai and Hasso Plattner Institute Launch New Institute for Digital Health
The Mount Sinai Health System (MSHS) and the Hasso Plattner Institute (HPI) today announced an affiliation that brings together industry leaders with combined expertise in health care delivery, health sciences, biomedical and digital engineering, machine learning and artificial intelligence to rapidly develop digital health products with real-time predictive and preventive capabilities that empower patients and health care providers, and improve health and health outcomes. Take a closer look.
|
SUNY Upstate Medical University: Professor Jean Sanger Named Fellow of the American Association of Anatomists
Jean Sanger, PhD., professor of cell and developmental biology, has been selected as a fellow of the American Association of Anatomists. Sanger will be recognized for her demonstrated excellence in science and her contributions to anatomical sciences April 9 at the Experimental Biology meeting in Orlando. Take a closer look.
|
Other News |
New York Medical College’s Graduate Student Research Forum Displays a Broad Field of Research
The Graduate Student Association in the Graduate School of Basic Medical Sciences (GSBMS) hosted the 31st Annual Graduate Student Research Forum (GSRF) on March 19, a day of great success as evidenced by the quality and depth of the student presentations and a keynote speech by renowned neuroscientist Marina Picciotto, Ph.D. Take a closer look.
|
